MicroRNA signatures highlight new breast cancer subtypes.

MicroRNAs (miRNAs) are a kind of short non-coding RNAs, of about 22 nucleotides in length, which modulate and sometimes degrade the target mRNAs thereby regulating a number of cellular functions. Recent research in this area establishes the involvement of miRNAs in various disease progressions, including certain types of cancer development. Further, genome-wide expression profiling of miRNAs has been proven to be useful for differentiating various cancer types. In this paper, we have used miRNA expression profiles over a large set of breast cancer tumor samples for identifying subtypes of breast cancers. The experimental results demonstrate that miRNAs carry a unique signature that distinguishes cancer subtypes and reveal new cancer subtypes. Additional survival analyses based on clinical data also strengthen this claim.

[1]  J. Klein,et al.  Survival Analysis: Techniques for Censored and Truncated Data , 1997 .

[2]  C. Croce,et al.  MicroRNA gene expression deregulation in human breast cancer. , 2005, Cancer research.

[3]  S. Ramaswamy,et al.  Translation of microarray data into clinically relevant cancer diagnostic tests using gene expression ratios in lung cancer and mesothelioma. , 2002, Cancer research.

[4]  C. Perou,et al.  Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. , 2006, JAMA.

[5]  Charles DeLisi,et al.  Pathway-based classification of cancer subtypes , 2012, Biology Direct.

[6]  H. Horvitz,et al.  MicroRNA expression profiles classify human cancers , 2005, Nature.

[7]  A. Nobel,et al.  Concordance among Gene-Expression – Based Predictors for Breast Cancer , 2011 .

[8]  M. He,et al.  MiR-124 targets Slug to regulate epithelial–mesenchymal transition and metastasis of breast cancer , 2012, Carcinogenesis.

[9]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[10]  Emad A. Rakha,et al.  Combinatorial biomarker expression in breast cancer , 2010, Breast Cancer Research and Treatment.

[11]  Rongwei Fu,et al.  Risk Factors for Breast Cancer for Women Aged 40 to 49 Years , 2012, Annals of Internal Medicine.

[12]  A. Nobel,et al.  The molecular portraits of breast tumors are conserved across microarray platforms , 2006, BMC Genomics.

[13]  Andrea Sottoriva,et al.  The shaping and functional consequences of the microRNA landscape in breast cancer , 2013, Nature.

[14]  G. Ball,et al.  High‐throughput protein expression analysis using tissue microarray technology of a large well‐characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses , 2005, International journal of cancer.

[15]  M. Yamakuchi.  MicroRNAs in Vascular Biology , 2012, International journal of vascular medicine.

[16]  S. Bandyopadhyay,et al.  In Silico Identification of OncomiRs in Different Cancer Types , 2012 .

[17]  Ujjwal Maulik,et al.  Multi-Class Clustering of Cancer Subtypes through SVM Based Ensemble of Pareto-Optimal Solutions for Gene Marker Identification , 2010, PloS one.

[18]  M. Ringnér,et al.  Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks , 2001, Nature Medicine.

[19]  Stefano Volinia,et al.  MicroRNA expression profiling of male breast cancer , 2009, Breast Cancer Research.

[20]  D. Cox.  Regression Models and Life-Tables , 1972 .

[21]  Yudong D. He,et al.  Gene expression profiling predicts clinical outcome of breast cancer , 2002, Nature.

[22]  D. Bartel.  MicroRNAs: Target Recognition and Regulatory Functions , 2009, Cell.

[23]  Roman Rouzier,et al.  Breast Cancer Molecular Subtypes Respond Differently to Preoperative Chemotherapy , 2005, Clinical Cancer Research.

[24]  Laura Ferreira,et al.  A Comparison of Hierarchical Methods for Clustering Functional Data , 2009, Commun. Stat. Simul. Comput..

[25]  S. Kauffman,et al.  Evolution before genes , 2012, Biology Direct.

[26]  J. H. Ward.  Hierarchical Grouping to Optimize an Objective Function , 1963 .

[27]  T. Nielsen,et al.  Breast cancer subtypes and the risk of local and regional relapse. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  A. Bednarek,et al.  Prognostic Relevance of Basal Cytokeratin Expression in Operable Breast Cancer , 2006, Oncology.

[29]  Lajos Pusztai,et al.  Gene-expression signatures in breast cancer. , 2009, The New England journal of medicine.

[30]  Leonard D. Goldstein,et al.  MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype , 2007, Genome Biology.

[31]  F. Markowetz,et al.  The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups , 2012, Nature.

[32]  Joshy George,et al.  Genetic reclassification of histologic grade delineates new clinical subtypes of breast cancer. , 2006, Cancer research.

[33]  Jeff Shrager,et al.  A Novel Classification of Lung Cancer into Molecular Subtypes , 2012, PloS one.

[34]  Alexander Schliep,et al.  Clustering cancer gene expression data: a comparative study , 2008, BMC Bioinformatics.